Clinical Trial Page
Clinical Trial Results:
A randomised, double-blind study comparing the efficacy and safety of 145mg NanoCrystal® fenofibrate, 10mg ezetimibe and their combination in patients with type IIb dyslipidemia and features of the metabolic syndrome.
| Summary | |
EudraCT number | 2004-002408-13 |
Trial protocol | DE BE |
Global completion date | 07 Apr 2006 |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
| Results information | |
Results version number | v1(current) |
This version publication date | 18 Dec 2019 |
First version publication date | 18 Dec 2019 |
Other versions | |
Summary report(s) | C LF 178P 0401 Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.